TOLVAPTANA in English translation

Examples of using Tolvaptana in Croatian and their translations into English

{-}
  • Colloquial category close
  • Ecclesiastic category close
  • Computer category close
Sigurnost i djelotvornost tolvaptana u djece i adolescenata mlađih od 18 godina još nije ustanovljena.
The safety and efficacy of tolvaptan in children and adolescents under the age of 18 years have not yet been established.
primjena tolvaptana mora se odmah prekinuti
administration of tolvaptan must be discontinued immediately
smanjenja doze tolvaptana i povećanje unosa tekućine.
reduce the dose of tolvaptan and increase fluid intake.
smanjenjem doze tolvaptana i povećanim uzimanjem tekućine.
reduce the dose of tolvaptan and increase fluid intake.
na farmakokinetiku tolvaptana ispitivan je u 87 bolesnika s bolešću jetre različitog porijekla.
on the pharmacokinetics of tolvaptan was investigated in 87 patients with liver disease of various origins.
Djelotvornost i sigurnost tolvaptana kod osoba sa klirensom kreatinina<
The efficacy and safety of tolvaptan in those with a creatinine clearance<
Primjena tolvaptana može dovesti do prebrzog povećanja serumskog natrija(≥ 12 mmol/l u 24 sata,
Administration of tolvaptan may cause too rapid increases in serum sodium(≥ 12 mmol/l per 24 hours,
Statini koji su se obično primjenjivali u fazi 3 pivotalnog ispitivanja tolvaptana(npr. rosuvastatin i pitavastatin) su supstrati za OATP1B1 ili OATP1B3, međutim nije uočena razlika u profilu nuspojava tijekom faze 3 pivotalnog ispitivanja tolvaptana u ADPBB-u.
Statins commonly used in the tolvaptan phase 3 pivotal trial(e.g., rosuvastatin and pitavastatin) are OATP1B1 or OATP1B3 substrates, however no difference in AE profile was observed during the phase 3 pivotal trial for tolvaptan in ADPKD.
Početna doza je 60 mg tolvaptana na dan u režimu s dvije podijeljene doze od 45 mg+ 15 mg 45 mg uzima se nakon buđenja i prije jutarnjeg obroka,
The initial dose is 60 mg tolvaptan per day as a split-dose regimen of 45 mg+ 15 mg 45 mg taken upon waking
Primarni cilj ispitivanja bilo je usporediti učinke tolvaptana+ SNJ sa placebom +SNJ na vrijeme do smrtnosti od bilo kojeg uzroka
The primary objective of the study was to compare the effects of tolvaptan+ SC with placebo+ SC on the time to all-cause mortality
tijekom intervala doziranja AUC) kada se davao istodobno sa više doza od 60 mg tolvaptana jednom dnevno.
the dosing interval AUC) when co administered with multiple once daily 60 mg doses of tolvaptan.
2 puta tijekom intervala doziranja) kada je primjenjivan istovremeno s višekratnim dozama od 60 mg tolvaptana jednom dnevno.
over the dosing interval[AUCτ]) when co administered with multiple once daily 60 mg doses of tolvaptan.
Iako se čini da istovremena upotreba tolvaptana s diureticima Henleove petlje
While there does not appear to be a synergistic or additive effect of concomitant use of tolvaptan with loop and thiazide diuretics,
Podaci o dugoročnoj sigurnosti i djelotvornosti tolvaptana bili su procijenjeni u kliničkom ispitivanju do 106 tjedna s bolesnicima(bilo koje etiologije)
Data on the long-term safety and efficacy of tolvaptan were assessed for up to 106 weeks in a clinical trial in patients(any aetiology)
Kod primjene tolvaptana u dozama višim od onih za odobrenu indikaciju, u kliničkim ispitivanjima s različitim potencijalnim indikacijama(autosomno dominantna policistična bolest bubrega) zapažena su oštećenja jetre uzrokovana lijekom vidjeti dio 4.8.
Drug induced liver injury has been observed in clinical trials investigating a different potential indication(autosomal dominant polycystic kidney disease) with long-term use of tolvaptan at higher doses than for the approved indication see section 4.8.
AUC tolvaptana kod bolesnika s teškim(Child-Pugh stadij C)
AUC of tolvaptan in severely(Child-Pugh class C)
Profil nuspojava tolvaptana za indikaciju ADPBB-a temelji se na bazi podataka kliničkog ispitivanja na 1444 liječena bolesnika(961 bolesnik liječen je tolvaptanom,
The adverse reaction profile of tolvaptan in the ADPKD indication is based on a clinical trial database of 1444 treated patients(961 patients treated with tolvaptan,
Primarni cilj ovog ispitivanja bio je procijeniti dugoročnu djelotvornost tolvaptana za ADPBB uz pomoć stope promjene(%)
The primary objective of this trial was to evaluate the long-term efficacy of tolvaptan in ADPKD through rate of total kidney volume(TKV)
smanjenjem doza tolvaptana i/ili diuretika
reduce doses of tolvaptan and/or diuretics
smanjenjem doze tolvaptana i/ili diuretika,
reduce doses of tolvaptan and/or diuretics,
Results: 76, Time: 0.0238

Top dictionary queries

Croatian - English